Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

FDA Wants ARCA to Run More Tests on Heart Drug

By Pharmaceutical Processing | June 1, 2009

BROOMFIELD, Colo. (AP) — The FDA wants ARCA Biopharma Inc. to run more clinical tests on its heart failure drug candidate Gencaro before it will consider approving the product. The FDA asked for additional studies to prove Gencaro is effective in preventing death from chronic heart failure, and to get more information on how the medicine interacts with other drugs. It also asked for additional non-clinical studies. ARCA did not say how long the additional studies could delay approval of the product. ARCA’s application to the FDA included data from a late-stage trial called BEST. The company said the FDA determined that the trial results do not prove Gencaro reduces death in patients with heart failure. The agency also had questions about integrity of data, and as a result, ARCA said it may have to conduct an independent audit of some of the sites involved in the trial. The agency also questioned the significance of data that ARCA said shows a patient’s genetic makeup predicts his or her response to Gencaro. ARCA said it submitted additional information on Gencaro in May. The FDA has not yet reviewed that information, and the company said that submission may address some of the FDA’s concerns.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE